HK Stock MarketDetailed Quotes
02172 MICROPORT NEURO
- 8.430
- +0.180+2.18%
Market Closed Jan 14 16:08 CST
4.87BMarket Cap19.74P/E (TTM)
8.530High8.100Low2.21MVolume8.160Open8.250Pre Close18.52MTurnover0.38%Turnover Ratio30.32P/E (Static)577.30MShares12.02052wk High2.60P/B4.87BFloat Cap6.13052wk Low0.19Dividend TTM577.30MShs Float26.610Historical High0.111Dividend LFY5.21%Amplitude6.130Historical Low8.364Avg Price1000Lot Size2.28%Div YieldTTM1.32%Div Yield LFY
About MICROPORT NEURO Company
Minimally Invasive Shentong was founded in 2012 under Minimally Invasive Medical Science Co., Ltd. (00853.HK). It has a complete line of interventional stroke treatment products and is committed to the research and development of high-end medical devices in the field of neurointerventional therapy.
Company Profile
Symbol02172
Company NameMICROPORT NEURO
ISINKYG6083E1098
Listing DateJul 15, 2022
Issue Price24.64
Shares Offered13.70M share(s)
FoundedSep 30, 2020
Registered AddressCayman Islands
Chairmanzhaohua chang
Secretaryzhaolin yang
Audit InstitutionKPMG, KPMG Huazhen (Special General Partnership)
Company CategoryOverseas registration of Mainland Individuals control
Registered OfficeP.O. Box 31119 Grand Pavilion Hibiscus Way, 802 West Bay Road, Grand Cayman KY1-1205 Cayman Islands
Head Office and Principal Place of BusinessRoom 1922, 19th floor, Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong
Fiscal Year Ends12-31
Employees534
MarketHong Kong motherboard
Phone(86)(21)38954600-55200
Fax(21)50801305
EmailNT_PresidentOffice@microport.com
Business Minimally Invasive Brain Science Co., Ltd. is an investment holding company mainly engaged in the development and production of neurointerventional medical devices. The company's product portfolio covers three major areas of cerebrovascular diseases, namely hemorrhagic stroke, atherosclerotic stenosis, and acute ischemic stroke. The company provides patients and doctors with integrated solutions for cerebrovascular diseases, including surgical and product education, treatment plan recommendations, surgical and device usage training, clinical support, and post-operative follow-up. The company's main products include Tubridge dense mesh stents, Fastrack microcatheter systems, WILLIS intracranial laminating stents, etc.
Company Executives
- Name
- Position
- Salary
- zhaohua chang
- Presidencies, Non-executive Directors
- --
- zhiyong xie
- CEOs, President, Executive Director, Chairman of Minimally Invasive Magic, Nomination Committee Members, Remuneration Committee Members, Authorized Representative
- --
- yiqun wang
- Executive Director, Executive Vice President
- --
- qingwei sun
- Non-executive Directors, Director of Minimally Invasive Magic
- --
- lin wang
- Non-executive Directors
- --
- xia wu
- Non-executive Directors
- --
- yi xu
- Independent Non-Executive Director, Remuneration Committee Chairman, Audit Committee Members, Nomination Committee Members
- --
- haixiao zhang
- Independent Non-Executive Director, Chairman of the Nomination Committee, Audit Committee Members
- --
- xin fan
- Independent Non-Executive Director, Chairman of the Audit Committee, Remuneration Committee Members
- --
- lei duan
- Chief Marketing Officer, Vice President of Neural Interventional Solutions Sales and Promotion
- --
- huina lu
- Senior Director of Quality, Registration and Clinical Affairs
- --
- wangcai liao
- Chief Technology Officer
- --
- zaoli wu
- Senior Director of Human Resources and Administration
- --
- zhuoping hou
- Senior Director of Finance
- --
- zhaolin yang
- Authorized Representative, Company Secretary
- --
Heat List
HK
Overall
Symbol
Price
% Chg
No Data